Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
June 20, 2023 08:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., June 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer...
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
May 02, 2023 17:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience Announces First Quarter 2023 Financial Results
April 25, 2023 08:01 ET
|
Harvard Bioscience, Inc.
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4...
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
April 18, 2023 17:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral...
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
April 17, 2023 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April...
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
March 16, 2023 17:14 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
March 16, 2023 09:25 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
March 09, 2023 07:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31,...
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
February 28, 2023 16:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on...
Harvard Bioscience Announces CFO Transition
December 12, 2022 08:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer...